Agüera-Ortiz, L., Frank-Garcìa, A., Gil, P. and Moreno, A. (2010). Clinical progression of moderate-to-severe Alzheimer’s disease and caregiver burden: a 12-month multicentre prospective observational study. International Psychogeriatrics, 22, 1265–1279.
Alzheimer’s Association. (2017). 2017 Alzheimer’s disease facts and figures. Alzheimer’s & Dementia, 13, 325–373.
Beinart, N., Weinman, J., Wade, D. and Brady, R. (2012). Caregiver burden and psychoeducational interventions in Alzheimer’s disease: a review. Dementia and Geriatric Cognitive Disorders Extra, 2, 638–648.
Belger, M. et al. (2016). How to deal with missing longitudinal data in cost of illness analysis in Alzheimer’s disease-suggestions from the GERAS observational study. BMC Medical Research Methodology, 16, 83.
Bergvall, N. et al. (2011). Relative importance of patient disease indicators on informal care and caregiver burden in Alzheimer’s disease. International Psychogeriatrics, 23, 73–85.
Brodaty, H., Woodward, M., Boundy, K., Ames, D. and Balshaw, R. (2014). Prevalence and predictors of burden in caregivers of people with dementia. American Journal of Geriatric Psychiatry, 22, 756–765.
Coley, N., Gardette, V., Cantet, C., Gillette-Guyonnet, S., Nourhashemi, F., Vellas, B. and Andrieu, S. (2011). How should we deal with missing data in clinical trials involving Alzheimer’s disease patients? Current Alzheimer Research, 28, 421–433.
Conde-Sala, J. L., Turró-Garriga, O., Calvó-Perxas, L., Vilalta-Franch, J., Lopez-Pousa, S. and Garre-Olmo, J. (2014). Three-year trajectories of caregiver burden in Alzheimer’s disease. Journal of Alzheimer’s Disease, 42, 623–633.
Cummings, J. L. (1997). The Neuropsychiatric Inventory: assessing psychopathology in dementia patients. Neurology, 48 Suppl 6, S10–S16.
Darbà, J., Kaskens, L. and Lacey, L. (2015). Relationship between global severity of patients with Alzheimer’s disease and costs of care in Spain; results from the co-dependence study in Spain. European Journal of Health Economics, 16, 895–905.
Dauphinot, V., Ravier, A., Novais, T., Delphin-Combe, F., Mouchoux, C. and Krolak-Salmon, P. (2016). Risk factors of caregiver burden evolution, for patients with subjective cognitive decline or neurocognitive disorders: a longitudinal analysis. Journal of the American Medical Directors Association, 17, 1037–1043.
Dodel, R. et al. (2015). Determinants of societal costs in Alzheimer’s disease: GERAS study baseline results. Alzheimer’s & Dementia, 11, 933–945.
Fisher, G. G. et al. (2011). Caring for individuals with dementia and cognitive impairment, not dementia: findings from the Aging, Demographics and Memory Study. Journal of the American Geriatric Society, 59, 488–494.
Folstein, M. F., Folstein, S.E. and McHugh, P. R. (1975). “Mini-mental state.” A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189–198.
Galasko, D., Schmitt, F., Thomas, R., Jin, S. and Bennett, D.; Alzheimer’s Disease Cooperative Study. (2005). Detailed assessment of activities of daily living in moderate to severe Alzheimer’s disease. Journal of the International Neuropsychological Society, 11, 446–453.
Gervès, C., Chauvin, P. and Bellanger, M. M. (2014). Evaluation of full costs of care for patients with Alzheimer’s disease in France: the predominant role of informal care. Health Policy, 116, 114–22.
Hardy, S. E., Allore, H. and Studenski, S. A. (2009). Missing data: a special challenge in aging research. Journal of the American Geriatric Society, 57, 722–729.
Jones, R. W. et al. (2017). Disease progression in mild dementia due to Alzheimer disease in an 18-month observational study (GERAS): the impact on costs and caregiver outcomes. Dementia and Geriatric Cognitive Disorders Extra, 7, 87–100.
Kim, H., Chang, M., Rose, K. and Kim, S. (2012) Predictors of caregiver burden in caregivers of individuals with dementia. Journal of Advanced Nursing, 68, 846–855.
Koca, E., Taşkapilioğlu, Ö. and Bakar, M. (2017). Caregiver burden in different stages of Alzheimer’s disease. Noro Psikiyatri Arsivi, 54, 82–86.
Laver, K., Dyer, S., Whitehead, C., Clemson, L. and Crotty, M. (2016). Interventions to delay functional decline in people with dementia: a systematic review of systematic reviews. BMJ Open, 6, e010767.
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D. and Stadlan, E. M. (1984). Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology, 34, 939–944.
National Institute for Health and Care Excellence. (2011). NICE technology appraisal guideline 217. Donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer’s disease. http://www.nice.org.uk/guidance/TA217; last accessed 26 June 2018.
Park, M., Sung, M., Kim, S. K., Kim, S. and Lee, D.Y. (2015). Multidimensional determinants of family caregiver burden in Alzheimer’s disease. International Psychogeriatrics, 27, 1355–1364.
Raccichini, A., Spazzafumo, L., Castellani, S., Civerchia, P., Pelliccioni, G. and Scarpino, O. (2015). Living with mild to moderate Alzheimer patients increases the caregiver’s burden at 6 months. American Journal of Alzheimer’s Disease and Other Dementias, 30, 463–467.
Reed, C. et al. (2014). Caregiver burden in Alzheimer’s disease: differential associations in adult-child and spousal caregivers in the GERAS observational study. Dementia and Geriatric Cognitive Disorders Extra, 4, 51–64.
Reed, C. et al. (2017). What drives country differences in cost of Alzheimer’s disease? An explanation from resource use in the GERAS study. Journal of Alzheimer’s Disease, 57, 797–812.
Rubin, D. B. (1987). Multiple Imputation for Nonresponse in Surveys. New York: John Wiley & Sons.
Shearer, J., Green, C., Ritchie, C. W. and Zajicek, J. P. (2012). Health state values for use in the economic evaluation of treatments for Alzheimer’s disease. Drugs & Aging, 29, 31–43.
Terum, T. M., Andersen, J. R., Rongve, A., Aarsland, D., Svendsboe, E. J. and Testad, I. (2017). The relationship of specific items on the Neuropsychiatric Inventory to caregiver burden in dementia: a systematic review. International Journal of Geriatric Psychiatry, 32, 703–717.
Viñas-Diez, V. et al. (2017). Kinship and cohabitation in relation to caregiver burden in the context of Alzheimer’s disease: a 24-month longitudinal study. International Journal of Geriatric Psychiatry, 32, 272–282.
Wimo, A. et al. (2013). The GERAS study: a prospective observational study of costs and resource use in community dwellers with Alzheimer’s disease in three European countries—study design and baseline findings. Journal of Alzheimer’s Disease, 36, 385–399.
Wimo, A. et al. (2017). Formal and informal care of community-living older people: a population-based study from the Swedish National Study on Aging and Care. The Journal of Nutrition, Health & Aging, 21, 17–24.
Wolfs, C. A. et al. (2012). Predictive factors for the objective burden of informal care in people with dementia: a systematic review. Alzheimer Disease and Associated Disorders, 26, 197–204.
Zarit, S. H., Reever, K. E. and Bach-Peterson, J. (1980). Relatives of the impaired elderly: correlates of feelings of burden. Gerontologist, 20, 649–665.
Zhu, C. W. et al. (2006). Clinical characteristics and longitudinal changes of informal cost of Alzheimer’s disease in the community. Journal of the American Geriatric Society, 54, 1596–1602.
Zhu, C. W. et al. (2008). Patient dependence and longitudinal changes in costs of care in Alzheimer’s disease. Dementia and Geriatric Cognitive Disorders, 26, 416–423.